Raymond James Financial reissued an outperform rating and acquired a new position in Boston Scientific shares.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Raymond James Financial reissued an outperform rating and acquired a new position in Boston Scientific shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Raymond James Financial
American Investment Bank and Financial Services Firm
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
-
MarketBeat
American personal finance blog
Related events
- Major financial firms, including Raymond James, Wells Fargo, Bank of America, and Morgan Stanley, have recently adjusted price targets and issued rating updates.
- Rating firms Raymond James Financial and TD Cowen provided reaffirmed buy ratings and price targets for a company listed on Nasdaq.
- Raymond James Financial and TD Cowen issued rating updates for GDS, alongside an insider transaction disclosure filed with the SEC.
- Keefe, Bruyette & Woods and Raymond James Financial upgraded the rating and target price for Invitation Homes shares on September 1, 2026.
- Analyst firm restated rating and target price for CeriBell on September 10, 2026.